Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Recruiting
×
Waldenstrom Macroglobulinemia
×
Clear all
Filters
3
NCT01804686
2026-03-12
CAN3001
Janssen Research & Development, LLC
Phase 3
Recruiting
700 enrolled